Prevalence of anemia and thrombocytopenia in pSS patients with positive anti-MDM2 was as high as 47.6% and 23.8% respectively, significant higher than pSS patients without anti-MDM2 autoantibody. Here, MDM2 is linked to anemia (phenotype).